Clinical distribution and drug resistance identification of 904 Enterobacter cloacae samples

Objective To investigate the clinical distribution and drug resistance of Enterobacter cloacae.Method Microscan Walkaway 40SI microbial identification and drug sensitivity analysis system was used to analyze 905 Enterobacter cloacae samples.Results Enterobacter cloacae mainly causes respiratory tract infection,and is sensitive to Imipeneln.The bacteria showed a drug resistance rate as high as 90% ～ 100% against first generation Cepholoporins and Penicillin antibiotics,about 30% against Cefoperazone/Sulbactam and Piperacillin/Sulbactam,and over 50% against other antibiotics.Conclusion Enterobacter cloacae shows high multi-drug resistance rate,which becomes more and more serious.The trend of drug resistance rate should be monitored,and the rational application of clinic antibiotics should be instructed.